GC Therapeutics
Developer of a genome-wide cell programming platform designed to convert patient-derived stem cells into multiple cell types. The company integrates synthetic biology, artificial intelligence, and pro...
Valuation
$135M
Market implied
Share Price
N/A
Total Raised
$74.7M
Last Round
Unknown
Latest Funding Round
Unknown
Investors
+14 other investors